Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2730]

Synthetic biology used to target cancer cells while sparing healthy tissue, study reports

Synthetic biology used to target cancer cells while sparing healthy tissue, study reports

Last Month in Oncology with Dr. Bishal Gyawali: April 2019

Last Month in Oncology with Dr. Bishal Gyawali: April 2019

HER2 positive breast cancer: Treatment de-escalation needs to be personalised

HER2 positive breast cancer: Treatment de-escalation needs to be personalised

Test allows doctors to determine most effective treatment for women with breast cancer

Test allows doctors to determine most effective treatment for women with breast cancer

Research decodes one way cancer survives treatment, proposes a way to prevent it

Research decodes one way cancer survives treatment, proposes a way to prevent it

EGLN inhibitor protects normal tissue and enables RT in mouse model of pancreatic cancer

EGLN inhibitor protects normal tissue and enables RT in mouse model of pancreatic cancer

Continuous chemotherapy improves outcomes and quality of life in advanced breast cancer

Continuous chemotherapy improves outcomes and quality of life in advanced breast cancer

Radiotherapy after chemotherapy may improve survival for patients with advanced Hodgkin’s lymphoma

Radiotherapy after chemotherapy may improve survival for patients with advanced Hodgkin’s lymphoma

Study in mice uncovers an unknown pathway for breast cancer tumours to recur

Study in mice uncovers an unknown pathway for breast cancer tumours to recur

Early, hormone-driven breast cancer is less likely to recur if treated with radiotherapy

Early, hormone-driven breast cancer is less likely to recur if treated with radiotherapy

More from ecancer